Hans Ackerman, National Heart, Lung, and Blood InstituteHans Ackerman is studying sickle-cell disease and malaria, which share an evolutionary link and many of the same disease-causing mechanisms that underlie vascular dysfunction. He is also studying how naturally occurring genetic differences in healthy people change nitric-oxide signaling and vasodilation responses in blood vessel walls.
Andrea Apolo, National Cancer InstituteAndrea Apolo is dedicated to improving the treatment and survival of patients with genitourinary tumors. Her research involves developing and designing clinical trials to test novel agents for the treatment of urologic cancers. Her primary research interest is in bladder cancer (urothelial carcinoma) and prostate cancer.
Falk Lohoff, National Institute on Alcohol Abuse and AlcoholismFalk Lohoff conducts preclinical and translational clinical studies with a focus on genomics and epigenetics related to the pathophysiology and treatment of alcohol-use disorders and addictions. In his preclinical work, which involves identifying molecular mechanisms involved in addictions, he uses methods such as human population genetics, genome-wide genotyping approaches, next-generation DNA and RNA sequencing, and epigenetic/proteomic profiling.